Breast Neoplasm Malignant Female Clinical Trial
Official title:
A Pivotal Study of REGENERA Implant in Malignant Breast Lesion Treated by Lumpectomy
The goals of this clinical trial are: - demonstrate the safety of REGENERA breast implant in patients undergoing lumpectomy of malignant breast lesions - demonstrate the safety and performance of REGENERA in terms of investigator's satisfaction, potential interference with current standard-of-care imaging techniques and occurrence of device-related serious adverse events. Participants will perform 13 study visits, and at each visit, all necessary study procedures will be performed according to the clinical investigation plan: - Screening - Pre-surgery treatment - Surgery and study device implant - Post-surgery follow-up up to 5 years
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04348955 -
Interest of Touch-massage in Hospital Day Care
|
||
| Completed |
NCT05812326 -
PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04424732 -
SBRT for Breast Cancer Oligometastases
|
N/A | |
| Completed |
NCT03109080 -
Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)
|
Phase 1 | |
| Recruiting |
NCT04198727 -
Study of the Impact of DPD Activity on the Efficacy of Capecitabine
|
N/A | |
| Completed |
NCT03525990 -
Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer Patients
|
N/A | |
| Recruiting |
NCT04289805 -
Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)
|
Phase 4 | |
| Available |
NCT05134922 -
Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009
|